top of page

Projects

On this page you will find a selection of my successfully implemented projects in the pharmaceutical and medical device industry. From the development of new drugs to strategic market positioning and regulatory strategy - my expertise is reflected in the variety of solutions used, but above all in the results.

Judge for yourself how I made pioneering products and groundbreaking approvals possible through in-depth know-how and close cooperation with my partners.

Approval Strategy for Microscopic Colitis

Development of an innovative regulatory strategy to obtain the world's first approval for the treatment and chronic therapy of microscopic colitis.

Johnson-Johnson-Logo-1024x576.png

Development of Dolormin for women

Conception of a preparation specifically for dysmenorrhea under the umbrella brand Dolormin, including naming, positioning, acquisition of a licence and identification of a suitable manufacturer.

Johnson-Johnson-Logo-1024x576.png

Introduction of Dolormin Migraine

Development and positioning of a migraine-specific medication under Dolormin brand with a special migraine indication, based on the identical formula of Dolormin extra.

Johnson-Johnson-Logo-1024x576.png

Imogas: Simethicone as a medical device

Development and implementation of the world's first oral medical device containing simethicone (Imogas), specifically for the relief of flatulence.

Johnson-Johnson-Logo-1024x576.png

OTC switch of famotidine

Famotidine was the first H2 blocker to be approved for over-the-counter use in Germany, in close cooperation with GSK to also have their H2 blocker ranitidine exempt from prescription requirements.

bottom of page